[Skip to Navigation]
Sign In

August 2021 - April 2016

Decade

Year

Issue

May 2021, Vol 6, No. 5, Pages 492-605

Original Investigation

Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction

Abstract Full Text
JAMA Cardiol. 2021;6(5):499-507. doi:10.1001/jamacardio.2020.7585

This secondary analysis of a randomized clinical trial examines the timing of the onset of clinical benefit with dapagliflozin and its magnitude as a function of proximity to prior heart failure hospitalization in patients with chronic heart failure with reduced ejection fraction.

Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life

Abstract Full Text
has active quiz
JAMA Cardiol. 2021;6(5):509-520. doi:10.1001/jamacardio.2021.0131

This cohort study assesses the independent associations of subclinical impairments in systolic performance with incident heart failure in late life in patients without heart failure.

Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction

Abstract Full Text
has audio
JAMA Cardiol. 2021;6(5):522-531. doi:10.1001/jamacardio.2021.0372

This registry-based cohort study compares the capture of clinically meaningful health status changes between physician-assigned New York Heart Association functional class and patient-reported outcome in Kansas City Cardiomyopathy Questionnaire Overall Summary Score for patients with chronic heart failure with reduced ejection fraction.

Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram

Abstract Full Text
JAMA Cardiol. 2021;6(5):532-538. doi:10.1001/jamacardio.2020.7422

This diagnostic study develops a model using artificial intelligence with deep neural networks based on 12-lead electrocardiograms to detect long QT syndrome in patients with electrocardiographically concealed long QT syndrome.

Long-term Clinical and Echocardiographic Outcomes in Young and Middle-aged Adults Undergoing the Ross Procedure

Abstract Full Text
JAMA Cardiol. 2021;6(5):539-548. doi:10.1001/jamacardio.2020.7434

This study evaluates the long-term clinical and echocardiographic outcomes in young and middle-aged patients undergoing pulmonary autograft procedure.

Magnetic Resonance Imaging in Patients With Cardiac Implantable Electronic Devices With Abandoned Leads

Abstract Full Text
JAMA Cardiol. 2021;6(5):549-556. doi:10.1001/jamacardio.2020.7572

This cohort study assesses if the performance of magnetic resonance imaging in the presence of an abandoned cardiac implantable electronic device lead is safe and whether there are deleterious effects on concomitant active cardiac implantable electronic device leads.

Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial

Abstract Full Text
has audio
JAMA Cardiol. 2021;6(5):558-567. doi:10.1001/jamacardio.2021.0038

This randomized clinical trial evaluates the use of continuous electrographic monitoring with a patch in older patients with hypertension to detect atrial fibrillation.

Brief Report

Estimated Prevalence of Masked Asleep Hypertension in US Adults

Abstract Full Text
JAMA Cardiol. 2021;6(5):568-573. doi:10.1001/jamacardio.2020.5212

This cohort study assesses the national prevalence of masked asleep hypertension among US adults.

Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project

Abstract Full Text
JAMA Cardiol. 2021;6(5):574-580. doi:10.1001/jamacardio.2020.5354

This cohort study describes temporal trends and institutional variations of multivessel percutaneous coronary intervention use for ST-elevation myocardial infarction in the United States between 2009 and 2018.

Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition

Abstract Full Text
JAMA Cardiol. 2021;6(5):582-586. doi:10.1001/jamacardio.2020.6184

This secondary exploratory analysis evaluates the association between baseline low-density lipoprotein cholesterol and the percentage low-density lipoprotein cholesterol reduction with a statin, ezetemibe, and a PCSK9 inhibitor using data from 3 randomized clinical trials

Association of Circulating Monocyte Chemoattractant Protein–1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies

Abstract Full Text
JAMA Cardiol. 2021;6(5):587-592. doi:10.1001/jamacardio.2020.5392

This meta-analysis of 7 population-based cohort studies assesses the association between circulating monocyte-chemoattractant protein–1 levels and risk of cardiovascular disease and death.

Editorial

Finding New Meaning in Everyday Electrocardiograms—Leveraging Deep Learning to Expand Our Diagnostic Toolkit

Abstract Full Text
JAMA Cardiol. 2021;6(5):493-494. doi:10.1001/jamacardio.2020.7460

Screening the Older Population for Atrial Fibrillation—Have We Moved the Needle Forward?

Abstract Full Text
has audio
JAMA Cardiol. 2021;6(5):495-496. doi:10.1001/jamacardio.2021.0052

The Growing Case for Routine Collection of Patient-Reported Outcomes

Abstract Full Text
has audio
JAMA Cardiol. 2021;6(5):497-498. doi:10.1001/jamacardio.2021.0391
Invited Commentary

Removing Obstacles to Magnetic Resonance Imaging for Patients With a Pacemaker or a Defibrillator

Abstract Full Text
JAMA Cardiol. 2021;6(5):556-557. doi:10.1001/jamacardio.2020.7593

Multivessel Percutaneous Coronary Intervention During ST-Elevation Myocardial Infarction—A Dickensian Debate That Never Ends

Abstract Full Text
JAMA Cardiol. 2021;6(5):580-581. doi:10.1001/jamacardio.2020.5361
Review

Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care: A Review

Abstract Full Text
JAMA Cardiol. 2021;6(5):593-599. doi:10.1001/jamacardio.2020.7478

This narrative review discusses the construction and face validity of the Seattle Angina Questionnaire, describes the alignment of its scores with clinical constructs, and explains how to interpret its scores as outcome measures in clinical trials and clinical care among patients with angina.

JAMA Cardiology Clinical Challenge

A Middle-aged Woman With Recurrent Chest Pain With Troponin Elevation and Unobstructed Coronary Arteries

Abstract Full Text
has active quiz has multimedia
JAMA Cardiol. 2021;6(5):600-601. doi:10.1001/jamacardio.2021.0116

A middle-aged woman presented with chest pain, elevated troponin-T, and anterior T-wave inversion on electrocardiography. What would you do next?

Comment & Response

Persistent Opioid Use May Be a Failure of Pain Management Rather Than Prescribing

Abstract Full Text
JAMA Cardiol. 2021;6(5):602. doi:10.1001/jamacardio.2020.6824

Persistent Opioid Use May Be a Failure of Pain Management Rather Than Prescribing—Reply

Abstract Full Text
JAMA Cardiol. 2021;6(5):602-603. doi:10.1001/jamacardio.2020.6835

To DOAC or Not to DOAC for Left Ventricular Thrombi—What Is the Dose?

Abstract Full Text
JAMA Cardiol. 2021;6(5):603-604. doi:10.1001/jamacardio.2020.6894

To DOAC or Not to DOAC for Left Ventricular Thrombi—What Is the Dose?—Reply

Abstract Full Text
JAMA Cardiol. 2021;6(5):604. doi:10.1001/jamacardio.2020.6897

Serum Monocyte-Chemoattractant Protein–1 Could Be an Indicator of Coronary Artery Calcium Score

Abstract Full Text
JAMA Cardiol. 2021;6(5):604-605. doi:10.1001/jamacardio.2021.0070

Serum Monocyte-Chemoattractant Protein–1 Could Be an Indicator of Coronary Artery Calcium Score—Reply

Abstract Full Text
JAMA Cardiol. 2021;6(5):605. doi:10.1001/jamacardio.2021.0073
Editor's Note

Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure—There Is No Time for Delay

Abstract Full Text
JAMA Cardiol. 2021;6(5):507-508. doi:10.1001/jamacardio.2020.7596

Is the Left Ventricular Ejection Fraction Measurement Still Preeminent?—New Measures to Quantify Subclinical Systolic Dysfunction

Abstract Full Text
JAMA Cardiol. 2021;6(5):521. doi:10.1001/jamacardio.2021.0143

Reconsidering the Ross Procedure

Abstract Full Text
JAMA Cardiol. 2021;6(5):548. doi:10.1001/jamacardio.2021.0087
Peer Reviewers List

JAMA Cardiology Peer Reviewers in 2020

Abstract Full Text
free access online only
JAMA Cardiol. 2021;6(5):e210151. doi:10.1001/jamacardio.2021.0151
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2021;6(5):492. doi:10.1001/jamacardio.2020.4552
×